Picture of medmix AG logo

MEDX — medmix AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Medmix AG Says HY Revenue At CHF 225.4 Million

July 23 (Reuters) - medmix AG MEDX.S:

MEDMIX AG: REVENUE AT CHF 225.4M HY

MEDMIX AG: REVISED 2025 REVENUE GUIDANCE: DECLINE SIMILAR TO THAT SEEN IN H1 2025

MEDMIX AG - H1 ADJUSTED. EBITDA MARGIN AT 19.9%, +80 BPS YOY

MEDMIX AG: CONFIRMED 2025 PROFITABILITY GUIDANCE: ADJUSTED EBITDA MARGIN 18% TO 19%

MEDMIX AG: CONFIRMED MID-TERM GUIDANCE: CAGR IN REVENUE OF ABOVE 4%, ADJUSTED. EBITDA MARGIN OF ABOVE 20%

Source text: [ID:]

Further company coverage: MEDX.S

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on medmix AG

See all news